Axa »

Celldex Therapeutics shares owned by Axa

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Axa from 13F filings

Historical chart of Axa investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Axa consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Axa

Quarter filed Position value Share count Share price at filing
2024-03-31 $6.0M 142k 41.97
2023-09-30 $4.0M 146k 27.52
2023-06-30 $3.9M 114k 33.93
2023-03-31 $4.0M 113k 35.98
2022-12-31 $5.0M 113k 44.57
2022-09-30 $4.5M 159k 28.11
2022-06-30 $3.4M 128k 26.96
2022-03-31 $5.3M 155k 34.06
2021-12-31 $6.2M 159k 38.75
2021-09-30 $8.8M 163k 54.05
2021-06-30 $7.7M 229k 33.42
2021-03-31 $6.1M 298k 20.60
2020-12-31 $184k 11k 17.52